Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Idioma
Intervalo de año de publicación
1.
Vopr Virusol ; 38(5): 216-8, 1993.
Artículo en Ruso | MEDLINE | ID: mdl-8284920

RESUMEN

Controlled epidemiological studies were carried out to evaluate two recombinant vaccines against hepatitis B of Cuban and Belgian production by the parameters of reactogenicity, safety and antigenic activity. Two groups of adult subjects (n = 73 each) and two groups of children (n = 30 each) were selected among those free from hepatitis B markers carrier state. The adults were given both preparations in a dose of 20 micrograms at intervals of 0-1-4 months, and the children received 10 micrograms at 0-1-2 months. The comparative studies showed both vaccines to be poorly reactogenic, safe and inducing anti-Hns in 80-100% of triply vaccinated subjects in titres within 100-500 IU. No statistically significant differences in the examined parameters were found in the two preparations tested.


Asunto(s)
Vacunas contra Hepatitis B/efectos adversos , Vacunas contra Hepatitis B/inmunología , Vacunas Sintéticas/efectos adversos , Vacunas Sintéticas/inmunología , Adolescente , Adulto , Bélgica , Niño , Preescolar , Cuba , Evaluación de Medicamentos , Hepatitis B/prevención & control , Anticuerpos contra la Hepatitis B/sangre , Humanos , Inmunización , Lactante , Factores de Tiempo , U.R.S.S.
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA